Yang Qinjun, Huang Wanqiu, Yin Dandan, Zhang Lu, Gao Yating, Tong Jiabing, Li Zegeng
Anhui University of Chinese Medicine, Hefei, China.
Key Laboratory of Xin'An Medicine, Ministry of Education, Hefei, China.
Front Genet. 2023 May 22;14:1128985. doi: 10.3389/fgene.2023.1128985. eCollection 2023.
Chronic obstructive pulmonary disease (COPD) affects approximately 400 million people worldwide and is associated with high mortality and morbidity. The effect of and gene polymorphisms on COPD risk has not been fully characterized. To investigate the association of and polymorphisms with COPD risk. A systematic search was conducted on 9 databases to identify studies published in English and Chinese. The analysis was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines (PRISMA). The pooled OR and 95% CI were calculated to evaluate the association of and polymorphisms with COPD risk. The I test, Q test, Egger's test, and Begg's test were conducted to determine the level of heterogeneity and publication bias of the included studies. In total, 857 articles were retrieved, among which 59 met the inclusion criteria. The rs1051740 polymorphism (homozygote, heterozygote, dominant, recessives, and allele model) was significantly associated with high risk of COPD risk. Subgroup analysis revealed that the rs1051740 polymorphism was significantly associated with COPD risk among Asians (homozygote, heterozygote, dominant, and allele model) and Caucasians (homozygote, dominant, recessives, and allele model). The rs2234922 polymorphism (heterozygote, dominant, and allele model) was significantly associated with a low risk of COPD. Subgroup analysis showed that the rs2234922 polymorphism (heterozygote, dominant, and allele model) was significantly associated with COPD risk among Asians. The rs1695 polymorphism (homozygote and recessives model) was significantly associated with COPD risk. Subgroup analysis showed that the rs1695 polymorphism (homozygote and recessives model) was significantly associated with COPD risk among Caucasians. The rs1138272 polymorphism (heterozygote and dominant model) was significantly associated with COPD risk. Subgroup analysis suggested that the rs1138272 polymorphism (heterozygote, dominant, and allele model) was significantly associated with COPD risk among Caucasians. The C allele in rs1051740 among Asians and the CC genotype among Caucasians may be risk factors for COPD. However, the GA genotype in rs2234922 may be a protective factor against COPD in Asians. The GG genotype in rs1695 and the TC genotype in rs1138272 may be risk factors for COPD, especially among Caucasians.
慢性阻塞性肺疾病(COPD)在全球约影响4亿人,且与高死亡率和高发病率相关。[具体基因名称]和[具体基因名称]基因多态性对COPD风险的影响尚未完全明确。为了研究[具体基因名称]和[具体基因名称]多态性与COPD风险的关联。我们对9个数据库进行了系统检索,以识别用英文和中文发表的研究。分析按照系统评价和Meta分析的首选报告项目(PRISMA)报告指南进行。计算合并的比值比(OR)和95%置信区间(CI),以评估[具体基因名称]和[具体基因名称]多态性与COPD风险的关联。进行I²检验、Q检验、Egger检验和Begg检验,以确定纳入研究的异质性水平和发表偏倚。总共检索到857篇文章,其中59篇符合纳入标准。[具体基因名称]的rs1051740多态性(纯合子、杂合子、显性、隐性和等位基因模型)与COPD高风险显著相关。亚组分析显示,[具体基因名称]的rs1051740多态性在亚洲人(纯合子、杂合子、显性和等位基因模型)和高加索人(纯合子、显性、隐性和等位基因模型)中与COPD风险显著相关。[具体基因名称]的rs2234922多态性(杂合子、显性和等位基因模型)与COPD低风险显著相关。亚组分析表明,[具体基因名称]的rs2234922多态性(杂合子、显性和等位基因模型)在亚洲人中与COPD风险显著相关。[具体基因名称]的rs1695多态性(纯合子和隐性模型)与COPD风险显著相关。亚组分析显示,[具体基因名称]的rs1695多态性(纯合子和隐性模型)在高加索人中与COPD风险显著相关。[具体基因名称]的rs1138272多态性(杂合子和显性模型)与COPD风险显著相关。亚组分析提示,[具体基因名称]的rs1138272多态性(杂合子、显性和等位基因模型)在高加索人中与COPD风险显著相关。亚洲人中[具体基因名称]的rs1051740中的C等位基因和高加索人中的CC基因型可能是COPD的危险因素。然而,[具体基因名称]的rs2234922中的GA基因型可能是亚洲人预防COPD的保护因素。[具体基因名称]的rs1695中的GG基因型和[具体基因名称]的rs1138272中的TC基因型可能是COPD的危险因素,尤其是在高加索人中。